[{"NetIncomeLoss_4_FY_USD":-11416358.0,"DepreciationAndAmortization_4_FY_USD":108583.0,"GeneralAndAdministrativeExpense_4_FY_USD":7120835.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_4_FY_shares":46330743.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_FY_USD":15154.0,"CommitmentsAndContingencies_0_FY_USD":null,"AccruedLiabilitiesCurrent_0_FY_USD":470636.0,"IncomeTaxReconciliationNondeductibleExpenseDepreciationAndAmortization_4_FY_USD":44278.0,"InterestPaidNet_4_FY_USD":null,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_FY_USD":-41416.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_FY_USD":1112536.0,"AccountsPayableRelatedPartiesCurrent_0_FY_USD":null,"NetCashProvidedByUsedInInvestingActivities_4_FY_USD":-184463.0,"Depreciation_4_FY_USD":93861.0,"OtherIndefiniteLivedIntangibleAssets_0_FY_USD":166464000.0,"ValuationAllowanceDeferredTaxAssetChangeInAmount_4_FY_USD":7739383.0,"AssetsCurrent_0_FY_USD":8941209.0,"OperatingLeaseExpense_4_FY_USD":359675.0,"DeferredTaxAssetsOperatingLossCarryforwards_0_FY_USD":6944248.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4_FY_shares":4091686.0,"CurrentStateAndLocalTaxExpenseBenefit_4_FY_USD":null,"ForeignCurrencyTransactionGainLossRealized_4_FY_USD":146828.0,"IncomeTaxesPaidNet_4_FY_USD":null,"CommonStockSharesIssued_0_FY_shares":46497409.0,"StockIssuedDuringPeriodValueIssuedForServices_4_FY_USD":144000.0,"DeferredTaxAssetsLiabilitiesNetCurrent_0_FY_USD":null,"Assets_0_FY_USD":178102059.0,"ShareBasedCompensation_4_FY_USD":884724.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_4_FY_USD":143234.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_FY_USD":154824000.0,"PreferredStockSharesOutstanding_0_FY_shares":0.0,"OperatingLeaseLiability_0_FY_USD":1803064.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_FY_USD":15154.0,"OperatingLeasesFutureMinimumPaymentsDueThereafter_0_FY_USD":574821.0,"PrepaidExpenseCurrent_0_FY_USD":242866.0,"IncreaseDecreaseInAccruedLiabilities_4_FY_USD":-251231.0,"GainsLossesOnExtinguishmentOfDebt_4_FY_USD":140000.0,"IncomeTaxExpenseBenefit_4_FY_USD":null,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_FY_USD":298305.0,"CommonStockValue_0_FY_USD":4650.0,"EffectOfExchangeRateOnCashAndCashEquivalents_4_FY_USD":-141978.0,"Revenues_4_FY_USD":null,"LongTermNotesPayable_0_FY_USD":4580787.0,"IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_4_FY_USD":761613.0,"DepositsAssetsNoncurrent_0_FY_USD":137550.0,"OperatingLeaseRightOfUseAsset_0_FY_USD":1703859.0,"OtherReceivablesNetCurrent_0_FY_USD":1982.0,"DepreciationDepletionAndAmortization_4_FY_USD":108584.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_4_FY_USD":-3585863.0,"IncomeTaxReconciliationChangeInEnactedTaxRate_4_FY_USD":-2828885.0,"NetCashProvidedByUsedInFinancingActivities_4_FY_USD":7200000.0,"CashCashEquivalentsAndShortTermInvestments_0_FY_USD":8160270.0,"ProceedsFromNotesPayable_4_FY_USD":5272700.0,"ComprehensiveIncomeNetOfTax_4_FY_USD":-11599592.0,"IncreaseDecreaseInAccountsPayable_4_FY_USD":59314.0,"AmortizationOfIntangibleAssets_4_FY_USD":14722.0,"CashAndCashEquivalentsAtCarryingValue_0_FY_USD":8696361.0,"OperatingLeaseLiabilityNoncurrent_0_FY_USD":1531779.0,"Cash_0_FY_USD":8696361.0,"Liabilities_0_FY_USD":11829798.0,"EquityFairValueAdjustment_4_FY_USD":-274566.0,"ResearchAndDevelopmentExpense_4_FY_USD":4694349.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_FY_shares":82237.0,"RepaymentsOfNotesPayable_4_FY_USD":272700.0,"CommonStockSharesOutstanding_0_FY_shares":46497409.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_FY_USD":15154.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_FY_USD":348495.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_FY_USD":15154.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_FY_USD":153013.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_FY_USD":246004.0,"Goodwill_0_FY_USD":11640000.0,"IncreaseDecreaseInAccountsPayableRelatedParties_4_FY_USD":-100000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-10459422.0,"ProceedsFromWarrantExercises_4_FY_USD":1000000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_FY_USD":3182434.0,"CostOfRevenue_4_FY_USD":null,"ConvertibleNotesPayable_0_FY_USD":1200000.0,"LiabilitiesCurrent_0_FY_USD":1334798.0,"SaleOfStockNumberOfSharesIssuedInTransaction_4_FY_shares":10000.0,"NonoperatingIncomeExpense_4_FY_USD":507410.0,"InterestExpense_4_FY_USD":104280.0,"GrossProfit_4_FY_USD":null,"OperatingLeaseWeightedAverageDiscountRatePercent_0_FY_pure":0.0399,"AdditionalPaidInCapital_0_FY_USD":230497225.0,"FiniteLivedIntangibleAssetsNet_0_FY_USD":77323.0,"IncreaseDecreaseInOperatingLiabilities_4_FY_USD":226533.0,"IncreaseDecreaseInOperatingAssets_4_FY_USD":-257685.0,"PreferredStockSharesIssued_0_FY_shares":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_FY_USD":1553.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_FY_USD":3182434.0,"PropertyPlantAndEquipmentNet_0_FY_USD":778118.0,"ProceedsFromConvertibleDebt_4_FY_USD":1200000.0,"IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4_FY_USD":2828885.0,"CurrentIncomeTaxExpenseBenefit_4_FY_USD":null,"RetainedEarningsAccumulatedDeficit_0_FY_USD":-64188198.0,"CommonStockParOrStatedValuePerShare_0_FY_USD":0.0001,"IncreaseDecreaseInAccountsAndOtherReceivables_4_FY_USD":-18812.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4_FY_USD":50897.0,"CommonStockSharesAuthorized_0_FY_shares":100000000.0,"OperatingIncomeLoss_4_FY_USD":-11923768.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_FY_shares":6655769.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4_FY_USD":-11416358.0,"AccountsPayableTradeCurrent_0_FY_USD":592877.0,"InvestmentIncomeInterest_4_FY_USD":50296.0,"FiniteLivedIntangibleAssetsGross_0_FY_USD":77323.0,"PreferredStockValue_0_FY_USD":null,"DeferredIncomeTaxExpenseBenefit_4_FY_USD":null,"LiabilitiesAndStockholdersEquity_0_FY_USD":178102059.0,"PreferredStockParOrStatedValuePerShare_0_FY_USD":0.0001,"PreferredStockSharesAuthorized_0_FY_shares":10000000.0,"DeferredTaxAssetsValuationAllowance_0_FY_USD":7739383.0,"OptionIndexedToIssuersEquityStrikePrice1_4_FY_USD":2.0,"PropertyPlantAndEquipmentGross_0_FY_USD":931131.0,"OperatingLeaseLiabilityCurrent_0_FY_USD":271285.0,"OperatingExpenses_4_FY_USD":11923768.0,"FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_4_FY_USD":-1254.0,"EarningsPerShareBasicAndDiluted_4_FY_USD":-0.25,"OperatingLeasesFutureMinimumPaymentsDueCurrent_0_FY_USD":338345.0,"StockholdersEquity_0_FY_USD":166272261.0,"PaymentsToAcquirePropertyPlantAndEquipment_4_FY_USD":184463.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_FY_USD":15154.0,"AssetsNoncurrent_0_FY_USD":168382732.0,"OperatingLeasesFutureMinimumPaymentsDueInFiveYears_0_FY_USD":253384.0,"AllocatedShareBasedCompensationExpense_4_FY_USD":884724.0,"OperatingLeasesFutureMinimumPaymentsDue_0_FY_USD":1803064.0,"Ticker":"ENOB","CIK":"1527728","name":"ENOCHIAN BIOSCIENCES INC","OfficialName":"Enochian Biosciences Inc. Common Stock","form":"10-K","period":"20200630","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"398960164.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200923"}]